Ophthalmoscopy as a method for assessing the pharmacological safety of drugs

Original article

УДК 617.7-072.1:615.015.4:619
DOI: 10.57034/2618723X-2023-04-03

E.V. Prudnikova*,
PhD, assistant at the Department of General, Private and Operative Surgery,
https://orcid.org/0000-0002-9866-1231
A.V. Bokarev,
DM, Associate Professor of the Department of General, Private and Operative Surgery,
https://orcid.org/0000-0002-4623-5388
A.O. Minina,
PhD, Associate Professor of the Department of General, Private and Operative Surgery,
https://orcid.org/0000-0002-4176-4053
E.Ya. Pilipets,
graduate student of the Department of General, Private and Operative,
https://orcid.org/0000-0002-0735-523Х

Federal State Budgetary Educational Institution of Higher Education “St. Petersburg State University of Veterinary Medicine”,
Russia, St. Petersburg, 196084, Chernigovskaya st., 5.

* E-mail: [email protected]


Keywords: ophthalmoscopy fundus retina toxic effect pharmacological safety

Acknowledgements

The study was performed without external funding.


For citation:

Prudnikova E.V., Bokarev A.V., Minina A.O., Pilipets E.Ya. Ophthalmoscopy as a method for assessing the pharmacological safety of drugs. Laboratory Animals for Science. 2023; 4. https://doi.org/10.57034/2618723X-2023-04-03

Abstract

The toxic effects of drugs can affect the anterior segment of the eye, the lens and the poste­rior segment of the eye. Оphthalmoscopy is used аor intravital assessment of the condition of the posterior segment of the eye. Сharacteristic changes, that can be observed by ophthalmoscopy, appear most often after systemic or intraocular use of drugs. However, before interpreting pathological ophthalmoscopic signs in laboratory animals, normal variations in the fundus pattern should be known, since among animal species there is a significant diversity in the structure of the fundus (presence or absence of tapetum, pigmentation, and type of nutrition of the retina). Pathological data obtained during ophthalmoscopy, indicating the toxic effect of the drug, can be expressed in the form of exudative, inflammatory, degenerative and atrophic processes, expansion and tortuosity of the retinal vessels, discoloration of the tapetum, retinal detachment, hemorrhages in the fundus, vascular attenuation of the retina and hyperreflectivity tapetum. Ophthalmoscopic examination is the most important tool for diagnosing pathologies of the posterior segment of the eyes in laboratory animals participating in the study of the pharmacological safety of drugs. Ophthalmoscopy should be carried out by a highly qualified veterinary ophthalmologist at all stages of the preclinical study of the drug.

Conflict of interest

The authors declare no conflict of interest.

Authors contribution

E.V. Prudnikova — analysis of literature data, writing the text of the article, provision of all photos from the personal archive.
A.O. Minina and E.Ya. Pilipets — analysis of literature data, addition to the text of the article.
A.V. Bokarev — critical revision of the text articles, approval of the final version of the article for publication.

References

  1. Assessing ocular toxicology in laboratory animals / edi­ted by R.J. Munger, M. Collins. NJ: Humana Totowa, 2012. P. 319.
  2. Maggs D.J. Slatters’s fundamentals of veterinary ophthalmology / D.J. Maggs, P.E. Miller, R. Ofri. St.-Louis: Elsevier, 2017. 584 p.
  3. Wolf E.D., Kuno H. Ophthalmic examination in preclinical safety studies // Anim. Eye Res. 1991. N. 10. P. 1–11.
  4. Willams D. Rabbit and rodent ophthalmology // EJCAP. 2007. N. 3. P. 242–252.
  5. Jekl V., Hauptman K., Knotek Z. Oculoscopy in rabbits // The veterinary clinics of North America. Exotic animal practice. 2015. N. 18. P. 417–430.
  6. Munger R.J. Veterinary ophthalmology in laboratory ani­mal studies // Vet Ophthalmol. 2002. N. 5. P. 167–175.
  7. Schiavo D.M. The use of laboratory animals in toxicology: an ophthalmoscopic assessment // Toxicologic pathology. 1990. N. 1. P. 222–223.
  8. Shibuya K., Tomohiro M., Sasaki Sh., Otake S. Characteristics of structures and lesions of the eye in laboratory animals used in toxicity studies // J. Toxicol Pathol. 2015. N. 28. P. 181–188. DOI: 10.1293/tox.2015-0037.
  9. Souza Monteiro de Araújo D., Brito R., Pereira-Figueiredo D. et al. Retinal toxicity induced by chemical agents // Int. J. Mol. Sci. 2022. N. 23. P. 1–23.
  10. Schiavo D.M. Retinopathy from administration of an imi­dazo quinazoline to beagles // Toxicol. Appl. Pharmacol. 1972. N. 23. P. 782–783.
  11. Epstein S.E., Hollingsworth S.R. Ivermectin-induced blindness treated with intravenous lipid therapy in a dog // Journal of Veterinary Emergency and Critical Care. 2013. N. 23. P. 58–62. DOI: 10.1111/vec.12016.
  12. Kenny P., Vernau K., Puschner B., Maggs D. Retinopathy associated with ivermectin toxicosis in two dogs // Journal of the American Veterinary Medical Association. 2008. N. 233. P. 279–284.
  13. Saqib M., Abbas G., Mughal M.N. Successful management of ivermectin-induced blindness in an African lion (Panthera leo) by intravenous administration of a li­pid emulsion // BMC Vet Res. 2015. N. 11. P. 287–290. DOI: 10.1186/s12917-015-0603-6.
  14. Aguirre S.A., Collette W., Gukasyan H.J., Huang W. An assessment of the ocular safety of excipient maleic acid following intravitreal injection in rabbits // Toxicologic pathology. 2012. N. 40. P. 797–806. DOI: 10.1177/0192623312441400.
  15. Peresypkina A.A., Gubareva V.O., Levkova E.A., Shabelnikova A.S. Correction of retinal angiopathy of hypertensive type by minoxidil, sildenafil in experiment // Research result. 2016. N. 4. P. 34–44.
  16. Ramirez C.J., Minch J.D., Gay J.M. et al. Molecular genetic basis for fluoroquinolone-induced retinal degene­ration in cats // Pharmacogenet Genomics. 2011. N. 2. P. 66–75. DOI: 10.1097/FPC.0b013e3283425f44.
  17. Gelatt K.N., van der Woerdt A., Ketring K.L. et al. Enrofloxacin-associated retinal degeneration in cats // Vet Ophthalmol. 2001. N. 2. P. 99–106.
  18. Imaki H., Messing J., Sturman J.A. Extensive Taurine Depletion and Retinal Degeneration in Cats Treated with β-Alanine for 40 Weeks // Taurine 3. Advances in Experimental Medicine and Biology. 1998. N. 442. P. 224–235.

Received: 2023-08-14
Reviewed: 2023-09-29
Accepted for publication: 2023-11-17

You may be interested